Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-04

FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application by Wilshire Pharmaceuticals, Inc. for dextroamphetamine sulfate, enabling a generic version of the stimulant to be m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)